NewsVandana Singh
Labcorp Holdings
LH · NYSE
$323.13+$4.30 (+1.35%)TodayMarket closed ·
Prev close $318.83
Latest news
- News
Myriad Genetics To Sell Its Prenatal Health Testing Business, Including Prequel, Foresight, SneakPeek And FirstGene Tests, To Labcorp For $210M In Cash Plus Inventory Value
- Press releaseGlobe Newswire
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
- NewsVandana Singh
OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal
- Press releasePRNewswire
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
- Press releasePRNewswire
Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test
- Press releasePRNewswire
Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026
- News
Labcorp Reaffirms 2026–2029 Long-Term Outlook Following CMS Preliminary Medicare Payment Rate Release; Expects Compound Annual Adj EPS Growth Of 8.5%-11.5% In 2026-2029
- NewsCaroline Ryan
Deal Dispatch: Bending Spoons Acquires Miro For $1.35B, Kinetik Up For Sale, LIV Golf Bankruptcy
- NewsVandana Singh
Labcorp Bets Big on AI, Specialty Testing to Drive Growth Through 2029
- News
Labcorp Provides Long-Term Outlook Through 2029, With 5%-8% Revenue CAGR And 8.5%-11.5% Adj EPS CAGR
- Press releasePRNewswire
Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day
- Press releasePRNewswire
Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update
- Press releasePRNewswire
Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials
- Press releasePRNewswire
Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity
- Press releasePRNewswire
Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
- Press releasePRNewswire
Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings
- Press releasePRNewswire
Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health
- Press releasePRNewswire
Labcorp to Host Investor Day on September 10, 2026
- Press releasePRNewswire
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma
- Press releasePRNewswire
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer
- News
Laboratory Corp Q2 Adj. EPS $4.99 Beats $4.78 Estimate, Sales $3.731B Beat $3.711B Estimate
- Press releasePRNewswire
Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance
- Press releasePRNewswire
Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing
- Press releasePRNewswire
Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026
- Press releasePRNewswire
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test
- Press releasePRNewswire
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
- Press releasePRNewswire
Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects
- Press releasePRNewswire
Labcorp to Present at the Jefferies Global Healthcare Conference
- Press releasePRNewswire
Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time
- Press releasePRNewswire
Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems
- Press releaseBusiness Wire
Knoa Pharma Begins Operations as a New, Public Health-Focused Company Dedicated to Supporting Patients and Abating the Opioid Crisis
- NewsVandana Singh
Labcorp Advances As AI Investments, Core Businesses Drive Growth
- Press releasePRNewswire
Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance
- Press releasePRNewswire
Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance
- Press releasePRNewswire
Labcorp Announces 2025 Fourth Quarter and Full Year Results
- News
NAMSA Acquires Labcorp's Early Development Medical Device Testing Operations; Financial Terms Not Disclosed
- Press releasePRNewswire
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
- News
Price Over Earnings Overview: Labcorp Hldgs
- Press releasePRNewswire
Labcorp Appoints Victor Bulto to Board of Directors
- Press releasePRNewswire
Labcorp Announces 2025 Third Quarter Results
- Press releasePRNewswire
Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU
- Press releasePRNewswire
Labcorp Announces 2025 Second Quarter Results
- Press releasePRNewswire
Labcorp Announces 2025 First Quarter Results
- News
Labcorp Expects 2025 Sales Of $13.88B-$14.05B Versus Consensus Of $13.79B, and Adjusted EPS Of $15.60-$16.40 Versus Consensus Of $16.02
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.